Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00050674 is registered in ClinicalTrials.gov with Schwartzberg, Lee, M.D. as lead sponsor.

NCT NCT00050674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00050674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma
Lead sponsor
Schwartzberg, Lee, M.D.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2001
Completion date
February 28, 2007
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer